ALA 8.33% 13.0¢ arovella therapeutics limited

Ann: European Anagrelide Cancer Patent, page-64

  1. 10,718 Posts.
    lightbulb Created with Sketch. 549
    It does seem a bigger gap but it is roughly 4 times either way, so the same ratio. The problem with consolidations is that they are frequently used for shares in a downtrend and the downtrend often continues so they are generally seen as negative imo.

    I personally don't see any benefit to doing a consolidation and would be quite happy if they never did one.

    I am really rapt that the 0.4c line has been wiped. The way things were looking at the beginning of the day, it wasn't looking likely. One small step...
    Last edited by ammie: 22/07/19
 
watchlist Created with Sketch. Add ALA (ASX) to my watchlist
(20min delay)
Last
13.0¢
Change
0.010(8.33%)
Mkt cap ! $136.5M
Open High Low Value Volume
12.5¢ 13.0¢ 12.0¢ $133.5K 1.063M

Buyers (Bids)

No. Vol. Price($)
1 11996 12.5¢
 

Sellers (Offers)

Price($) Vol. No.
13.0¢ 367267 9
View Market Depth
Last trade - 16.10pm 03/05/2024 (20 minute delay) ?
Last
12.8¢
  Change
0.010 ( 6.25 %)
Open High Low Volume
12.5¢ 13.0¢ 12.5¢ 582454
Last updated 14.53pm 03/05/2024 ?
ALA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.